Five Oceans Advisors Gilead Sciences, Inc. Transaction History

Five Oceans Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$71.58 - $87.29 $1,574 - $1,920	-22 Reduced 0.66%	3,302 $241,000
Q4 2023 Jan 22, 2024	SELL	$73.27 - $83.09 $2,564 - $2,908	-35 Reduced 1.04%	3,324 $269,000
Q3 2023 Oct 17, 2023	BUY	$73.94 - $80.67 $221 - $242	3 Added 0.09%	3,359 $251,000
Q2 2023 Jul 14, 2023	BUY	$76.01 - $86.7 $6,992 - $7,976	92 Added 2.82%	3,356 $258,000
Q1 2023 Apr 14, 2023	BUY	$77.31 - $88.08 $35,639 - $40,604	461 Added 16.45%	3,264 $270,000
Q4 2022 Jan 17, 2023	BUY	$62.32 - $89.47 $174,682 - $250,784	2,803 New	2,803 $0

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Five Oceans Advisors, based on Form 13F filings with the SEC.

Stay updated on Five Oceans Advisors with notifications on news.